Učitavanje...

One gene to rule them all…and in the darkness bind them

Pharmaceutical inhibition of the Human Epidermal growth factor Receptor 2 (HER2) oncogene has dramatically improved outcomes in HER2-amplified breast cancers. However, monotherapy HER2 inhibitors are not effective. We have recently reported that a co-amplified microRNA within the HER2 amplicon, lead...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Cell Oncol
Glavni autori: Floros, Konstantinos V., Faber, Anthony C.
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149778/
https://ncbi.nlm.nih.gov/pubmed/30250918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1465881
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!